Insider Selling: Phreesia, Inc. (NYSE:PHR) CFO Sells $159,135.37 in Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 5,827 shares of the firm’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $27.31, for a total value of $159,135.37. Following the transaction, the chief financial officer now owns 141,846 shares in the company, valued at $3,873,814.26. This trade represents a 3.95 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Balaji Gandhi also recently made the following trade(s):

• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total transaction of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $85,018.95.

Phreesia Stock Up 2.3 %

Phreesia stock opened at $27.89 on Friday. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $29.16. The stock has a market cap of $1.62 billion, a price-to-earnings ratio of -18.98 and a beta of 0.94. The company’s 50-day moving average price is $24.00 and its two-hundred day moving average price is $23.00. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last announced its earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.04. The firm had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.58) earnings per share. On average, analysts expect that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on PHR. Truist Financial raised their target price on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. JMP Securities reissued a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a report on Tuesday, December 10th. KeyCorp upped their price objective on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th. Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 target price on shares of Phreesia in a research report on Friday, January 10th. Finally, Robert W. Baird reduced their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $31.00.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Trust Point Inc. boosted its holdings in shares of Phreesia by 3.5% in the third quarter. Trust Point Inc. now owns 17,887 shares of the company’s stock worth $408,000 after buying an additional 607 shares during the period. Ensign Peak Advisors Inc boosted its stake in Phreesia by 3.2% in the 2nd quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock worth $477,000 after purchasing an additional 700 shares during the period. The Manufacturers Life Insurance Company boosted its stake in Phreesia by 3.3% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 27,935 shares of the company’s stock worth $637,000 after purchasing an additional 905 shares during the period. MetLife Investment Management LLC grew its position in Phreesia by 3.8% during the 3rd quarter. MetLife Investment Management LLC now owns 30,781 shares of the company’s stock worth $701,000 after purchasing an additional 1,120 shares in the last quarter. Finally, R Squared Ltd acquired a new stake in Phreesia during the 4th quarter valued at $30,000. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.